Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations?
Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study Carlos Lorenzo , MD 1 , Manel...
Saved in:
Published in | Diabetes care Vol. 24; no. 12; pp. 2059 - 2064 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
American Diabetes Association
01.12.2001
|
Online Access | Get full text |
Cover
Loading…
Abstract | Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2
Diabetes in Mexican-Origin Populations?
The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study
Carlos Lorenzo , MD 1 ,
Manel Serrano-Rios , MD 2 ,
Maria T. Martinez-Larrad , MD 2 ,
Rafael Gabriel , MD 3 ,
Ken Williams , MS 1 ,
Clicerio Gonzalez-Villalpando , MD 4 ,
Michel P. Stern , MD 1 ,
Helen P. Hazuda , PHD 1 and
Steven M. Haffner , MD 1
1 Department of Medicine, Division of Clinical Epidemiology, University of Texas Health Science Center at San Antonio, San Antonio,
Texas
2 Department of Internal Medicine, Hospital Universitario de San Carlos, Madrid, Spain
3 Department of Internal Medicine, Hospital de La Princesa, Madrid, Spain
4 Center of Studies in Diabetes, American British Cowdray Hospital, Mexico City, Mexico
Abstract
OBJECTIVE —Mexican-American populations in San Antonio, Texas (SA-MA) and Mexico have a higher prevalence of type 2 diabetes than non-Hispanic
whites in San Antonio (SA-NHW). However, the higher prevalence of type 2 diabetes in Mexican-origin populations might be related,
in part, not to Native American genetic admixture but to Spanish genetic admixture.
RESEARCH DESIGN AND METHODS —Four population-based epidemiological surveys conducted with Mexican-origin and European-origin samples provided data relevant
to this question. In all four surveys, type 2 diabetes was defined as fasting plasma glucose ≥7.0 mmol/l or 2-h glucose ≥11.1
mmol/l or use of antidiabetic agents.
RESULTS —A comparison of the two Mexican-origin populations showed that the age- and sex-adjusted prevalence of type 2 diabetes was
lower in Mexico than in SA-MA (15.1 vs. 17.9%, P = 0.032). Between the two European-origin populations, the prevalence of type 2 diabetes was lower in SA-NHW than in Spain
(6.2 vs. 9.1%, P < 0.0001), but differences were attenuated by adjustment for BMI or after stratification by education. In logistic regression
analyses, type 2 diabetes was associated with Mexican ethnic origin after adjusting for age, education, BMI, and waist-to-hip
ratio.
CONCLUSIONS —The prevalence of type 2 diabetes in Spain was intermediate between that in Mexican-origin populations and SA-NHW. Although
the higher degree of Native American admixture is a major contributor to the higher rates of type 2 diabetes, we cannot completely
rule out a partial contribution of Spanish admixture to diabetes susceptibility among Mexican- origin populations.
MCDS, Mexico City Diabetes Study
OR, odds ratio
SAHS, San Antonio Heart Study
SA-NHW, non-Hispanic whites in San Antonio
SA-MA, Mexican-Americans in San Antonio
SIRS, Spanish Insulin Resistance Study
WHR, waist-to-hip ratio
Footnotes
Address correspondence and reprint requests to Carlos Lorenzo, MD, Department of Medicine, Division of Clinical Epidemiology,
University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78284-7873. E-mail: lorenzo{at}uthscsa.edu .
Received for publication 4 May 2001 and accepted in revised form 4 September 2001.
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. |
---|---|
AbstractList | OBJECTIVE—Mexican-American populations in San Antonio, Texas (SA-MA) and Mexico have a higher prevalence of type 2 diabetes than non-Hispanic whites in San Antonio (SA-NHW). However, the higher prevalence of type 2 diabetes in Mexican-origin populations might be related, in part, not to Native American genetic admixture but to Spanish genetic admixture.
RESEARCH DESIGN AND METHODS—Four population-based epidemiological surveys conducted with Mexican-origin and European-origin samples provided data relevant to this question. In all four surveys, type 2 diabetes was defined as fasting plasma glucose ≥7.0 mmol/l or 2-h glucose ≥11.1 mmol/l or use of antidiabetic agents.
RESULTS—A comparison of the two Mexican-origin populations showed that the age- and sex-adjusted prevalence of type 2 diabetes was lower in Mexico than in SA-MA (15.1 vs. 17.9%, P = 0.032). Between the two European-origin populations, the prevalence of type 2 diabetes was lower in SA-NHW than in Spain (6.2 vs. 9.1%, P < 0.0001), but differences were attenuated by adjustment for BMI or after stratification by education. In logistic regression analyses, type 2 diabetes was associated with Mexican ethnic origin after adjusting for age, education, BMI, and waist-to-hip ratio.
CONCLUSIONS—The prevalence of type 2 diabetes in Spain was intermediate between that in Mexican-origin populations and SA-NHW. Although the higher degree of Native American admixture is a major contributor to the higher rates of type 2 diabetes, we cannot completely rule out a partial contribution of Spanish admixture to diabetes susceptibility among Mexican- origin populations. Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study Carlos Lorenzo , MD 1 , Manel Serrano-Rios , MD 2 , Maria T. Martinez-Larrad , MD 2 , Rafael Gabriel , MD 3 , Ken Williams , MS 1 , Clicerio Gonzalez-Villalpando , MD 4 , Michel P. Stern , MD 1 , Helen P. Hazuda , PHD 1 and Steven M. Haffner , MD 1 1 Department of Medicine, Division of Clinical Epidemiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 2 Department of Internal Medicine, Hospital Universitario de San Carlos, Madrid, Spain 3 Department of Internal Medicine, Hospital de La Princesa, Madrid, Spain 4 Center of Studies in Diabetes, American British Cowdray Hospital, Mexico City, Mexico Abstract OBJECTIVE —Mexican-American populations in San Antonio, Texas (SA-MA) and Mexico have a higher prevalence of type 2 diabetes than non-Hispanic whites in San Antonio (SA-NHW). However, the higher prevalence of type 2 diabetes in Mexican-origin populations might be related, in part, not to Native American genetic admixture but to Spanish genetic admixture. RESEARCH DESIGN AND METHODS —Four population-based epidemiological surveys conducted with Mexican-origin and European-origin samples provided data relevant to this question. In all four surveys, type 2 diabetes was defined as fasting plasma glucose ≥7.0 mmol/l or 2-h glucose ≥11.1 mmol/l or use of antidiabetic agents. RESULTS —A comparison of the two Mexican-origin populations showed that the age- and sex-adjusted prevalence of type 2 diabetes was lower in Mexico than in SA-MA (15.1 vs. 17.9%, P = 0.032). Between the two European-origin populations, the prevalence of type 2 diabetes was lower in SA-NHW than in Spain (6.2 vs. 9.1%, P < 0.0001), but differences were attenuated by adjustment for BMI or after stratification by education. In logistic regression analyses, type 2 diabetes was associated with Mexican ethnic origin after adjusting for age, education, BMI, and waist-to-hip ratio. CONCLUSIONS —The prevalence of type 2 diabetes in Spain was intermediate between that in Mexican-origin populations and SA-NHW. Although the higher degree of Native American admixture is a major contributor to the higher rates of type 2 diabetes, we cannot completely rule out a partial contribution of Spanish admixture to diabetes susceptibility among Mexican- origin populations. MCDS, Mexico City Diabetes Study OR, odds ratio SAHS, San Antonio Heart Study SA-NHW, non-Hispanic whites in San Antonio SA-MA, Mexican-Americans in San Antonio SIRS, Spanish Insulin Resistance Study WHR, waist-to-hip ratio Footnotes Address correspondence and reprint requests to Carlos Lorenzo, MD, Department of Medicine, Division of Clinical Epidemiology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78284-7873. E-mail: lorenzo{at}uthscsa.edu . Received for publication 4 May 2001 and accepted in revised form 4 September 2001. A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. |
Author | Maria T. Martinez-Larrad Carlos Lorenzo Clicerio Gonzalez-Villalpando Michel P. Stern Helen P. Hazuda Ken Williams Steven M. Haffner Manel Serrano-Rios Rafael Gabriel |
Author_xml | – sequence: 1 fullname: Carlos Lorenzo – sequence: 2 fullname: Manel Serrano-Rios – sequence: 3 fullname: Maria T. Martinez-Larrad – sequence: 4 fullname: Rafael Gabriel – sequence: 5 fullname: Ken Williams – sequence: 6 fullname: Clicerio Gonzalez-Villalpando – sequence: 7 fullname: Michel P. Stern – sequence: 8 fullname: Helen P. Hazuda – sequence: 9 fullname: Steven M. Haffner |
BookMark | eNptkM1OwzAQhC1URH_gBTj5jhJsx2njE0IFWqSiRlDEMXKcTWsU7MhOgT4Ob0pCc-S0Wu3Mp50Zo4GxBhC6pCRkUTS7LrRU0kHIeEhZyEgsTtCIiigO4pgnAzQilIsgFoIN0dj7d0II50lyhoaUzlhEkmiEft6kx80O8FL7xjqt8Nyaxul832hrsC3xSy21wY39Uz3Bt1bS4AUYwKm1FU6la7SsqgN-Bl9b43VeAS6t66nbHTicOviUFRgFHXFzqAEzfKdlDg143OJ7brB2etuuqa33lew-8Dfn6LSUlYeLfk7Q68P9Zr4MVuvF4_x2FSjGiQiAcpWD4kLxSLAZK0AoksQ5JVNWiGmcC2B5XCZT4JLP2vAFLdhUqqhMBCRcRBPEjlzlrPcOyqx2-kO6Q0ZJ1vWd9X1njGeUZV3frenqaNq1Qb90eyz6VP-pfwFzAYZP |
CitedBy_id | crossref_primary_10_1157_13080210 crossref_primary_10_1007_s00439_010_0803_x crossref_primary_10_1016_S0025_7753_03_73614_8 crossref_primary_10_2337_db06_0905 crossref_primary_10_1016_j_rceng_2021_06_002 crossref_primary_10_1016_S0188_4409_03_00069_9 crossref_primary_10_1016_j_rce_2021_06_002 crossref_primary_10_1186_s12889_020_8378_5 crossref_primary_10_1038_oby_2003_198 crossref_primary_10_1097_00004872_200308000_00009 crossref_primary_10_1111_j_1464_5491_2012_03723_x crossref_primary_10_1111_j_1464_5491_2005_01739_x crossref_primary_10_1007_s11892_005_0012_5 crossref_primary_10_1177_0898264307309924 crossref_primary_10_1016_j_ecl_2004_03_005 crossref_primary_10_1016_j_gene_2013_03_024 crossref_primary_10_1089_met_2006_4_1 crossref_primary_10_1161_HYPERTENSIONAHA_107_096263 crossref_primary_10_1157_13109554 crossref_primary_10_1016_j_socscimed_2004_11_040 crossref_primary_10_1016_S1262_3636_07_70125_8 crossref_primary_10_1016_j_amjmed_2011_07_019 crossref_primary_10_1016_j_amjmed_2011_07_018 crossref_primary_10_1016_j_arcmed_2005_01_006 crossref_primary_10_1016_j_gene_2015_03_065 crossref_primary_10_1093_hmg_ddq173 crossref_primary_10_2337_db07_0482 crossref_primary_10_1002_dmrr_244 crossref_primary_10_1157_13127917 crossref_primary_10_1186_1471_2164_11_326 crossref_primary_10_1007_s10549_011_1546_7 crossref_primary_10_2337_diacare_26_1_61 crossref_primary_10_4158_EP_13_1_77 crossref_primary_10_1186_1471_2350_11_148 crossref_primary_10_1002_dmrr_3097 crossref_primary_10_1038_oby_2003_86 crossref_primary_10_1007_s00439_003_0912_x crossref_primary_10_1177_1474651403003001S0201 crossref_primary_10_1111_acer_13576 crossref_primary_10_18705_1607_419X_2007_13_2_95_112 crossref_primary_10_1371_journal_pone_0019327 crossref_primary_10_1038_s41598_019_39145_x crossref_primary_10_1046_j_1365_2265_2003_01871_x crossref_primary_10_1016_j_metabol_2004_06_006 crossref_primary_10_1038_s41598_019_45389_4 crossref_primary_10_1080_19485565_2005_9989105 crossref_primary_10_1016_j_jacc_2008_12_037 crossref_primary_10_1016_j_arcmed_2020_05_010 |
Cites_doi | 10.1002/ajpa.1330290502 10.2337/diabetes.44.12.1386 10.2337/diacare.14.2.102 10.1093/ajcn/61.4.765 10.1093/oxfordjournals.aje.a113956 10.1001/archinte.156.17.1994 10.2337/diacare.20.5.773 10.1017/S0007114500001082 10.1093/oxfordjournals.aje.a116731 10.2337/diacare.20.7.1183 10.2337/diab.33.1.86 10.2337/diab.41.4.484 10.1093/oxfordjournals.aje.a114228 10.1056/NEJM198607243150403 10.1161/01.CIR.90.3.1542 10.1016/S1047-2797(96)00026-9 10.2105/AJPH.89.5.723 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.2337/diacare.24.12.2059 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1935-5548 |
EndPage | 2064 |
ExternalDocumentID | 10_2337_diacare_24_12_2059 diacare_24_12_2059 |
GroupedDBID | - 08R 0R 1AW 29F 2WC 3V. 4.4 41 53G 55 5B 5GY 5RE 5RS 5VS 7RV 7X2 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AAIKC AASXA AAWTL AAYEP ABFLS ABOCM ABPPZ ABPTK ABUWG ACGOD ACJLH ACVYA ADACO ADBBV ADBIT AENEX AFDAS AFFNX AFKRA AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AN0 AQUVI ATCPS AZQEC BAWUL BBAFP BCR BCU BEC BENPR BHPHI BKEYQ BKNYI BLC BNQBC BPHCQ BVXVI C1A CS3 DIK DU5 DWQXO E3Z EBS EDB EJD ET EX3 F5P FYUFA GJ GNUQQ GUQSH GX1 H13 HCIFZ HZ IAG IAO IEA IGG IHR INH INR IOF IPO ITC J5H K9- KM KQ8 L7B M0K M0R M0T M1P M2O M2P M2Q M5 MBDVC O0- O9- OK1 OVD P2P PADUT PCD PEA PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q2X RHF RHI S0X SJFOW SV3 TDI TWZ WH7 WOQ WOW X7M XZ ZA5 ZGI ZXP --- -ET ..I .55 .GJ .XZ 08P 0R~ 18M 41~ 6PF AAKAS AAMNW AAYXX ACGFO ADZCM AEGXH AERZD AFOSN AIAGR ALIPV BTFSW CCPQU CITATION EMOBN HMCUK HZ~ M5~ N4W NAPCQ TEORI TR2 UKHRP VVN W8F WHG YHG YOC ~KM |
ID | FETCH-LOGICAL-c2409-e14cbec49c439272de9c085b1062d965b9e2b5f86e4a47308d1d26ac3f89e8493 |
ISSN | 0149-5992 |
IngestDate | Fri Aug 23 01:52:49 EDT 2024 Fri Jan 15 19:48:12 EST 2021 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2409-e14cbec49c439272de9c085b1062d965b9e2b5f86e4a47308d1d26ac3f89e8493 |
OpenAccessLink | https://diabetesjournals.org/care/article-pdf/24/12/2059/587520/dc1201002059.pdf |
PMID | 11723083 |
PageCount | 6 |
ParticipantIDs | highwire_diabetes_diacare_24_12_2059 crossref_primary_10_2337_diacare_24_12_2059 |
ProviderPackageCode | RHF RHI |
PublicationCentury | 2000 |
PublicationDate | 20011201 |
PublicationDateYYYYMMDD | 2001-12-01 |
PublicationDate_xml | – month: 12 year: 2001 text: 20011201 day: 01 |
PublicationDecade | 2000 |
PublicationTitle | Diabetes care |
PublicationYear | 2001 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
References | 2022031213255934800_R7 2022031213255934800_R8 2022031213255934800_R9 2022031213255934800_R3 2022031213255934800_R11 2022031213255934800_R22 2022031213255934800_R4 2022031213255934800_R10 2022031213255934800_R21 2022031213255934800_R5 2022031213255934800_R20 2022031213255934800_R6 2022031213255934800_R1 2022031213255934800_R2 2022031213255934800_R19 2022031213255934800_R18 2022031213255934800_R17 2022031213255934800_R16 2022031213255934800_R15 2022031213255934800_R14 2022031213255934800_R13 2022031213255934800_R24 2022031213255934800_R12 2022031213255934800_R23 |
References_xml | – ident: 2022031213255934800_R2 doi: 10.1002/ajpa.1330290502 – ident: 2022031213255934800_R9 doi: 10.2337/diabetes.44.12.1386 – ident: 2022031213255934800_R10 doi: 10.2337/diacare.14.2.102 – ident: 2022031213255934800_R23 doi: 10.1093/ajcn/61.4.765 – ident: 2022031213255934800_R4 doi: 10.1093/oxfordjournals.aje.a113956 – ident: 2022031213255934800_R11 doi: 10.1001/archinte.156.17.1994 – ident: 2022031213255934800_R19 – ident: 2022031213255934800_R12 doi: 10.2337/diacare.20.5.773 – ident: 2022031213255934800_R16 – ident: 2022031213255934800_R17 – ident: 2022031213255934800_R24 doi: 10.1017/S0007114500001082 – ident: 2022031213255934800_R15 – ident: 2022031213255934800_R14 – ident: 2022031213255934800_R22 doi: 10.1093/oxfordjournals.aje.a116731 – ident: 2022031213255934800_R18 doi: 10.2337/diacare.20.7.1183 – ident: 2022031213255934800_R20 – ident: 2022031213255934800_R1 doi: 10.2337/diab.33.1.86 – ident: 2022031213255934800_R5 doi: 10.2337/diab.41.4.484 – ident: 2022031213255934800_R7 doi: 10.1093/oxfordjournals.aje.a114228 – ident: 2022031213255934800_R8 doi: 10.1056/NEJM198607243150403 – ident: 2022031213255934800_R13 doi: 10.1161/01.CIR.90.3.1542 – ident: 2022031213255934800_R3 doi: 10.1016/S1047-2797(96)00026-9 – ident: 2022031213255934800_R21 – ident: 2022031213255934800_R6 doi: 10.2105/AJPH.89.5.723 |
SSID | ssj0004488 |
Score | 1.9746749 |
Snippet | Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2
Diabetes in Mexican-Origin... OBJECTIVE—Mexican-American populations in San Antonio, Texas (SA-MA) and Mexico have a higher prevalence of type 2 diabetes than non-Hispanic whites in San... |
SourceID | crossref highwire |
SourceType | Aggregation Database Publisher |
StartPage | 2059 |
Title | Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations? |
URI | http://care.diabetesjournals.org/content/24/12/2059.abstract |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZB2MvY1fWdRt66FtQFsuXWE9jdBtlLFspKeubkWQJAsEuaQoj_2Z_rb9k5-hiu1kH615MYuQPx-fz0TnKd44IOcy0ytIik8xYO2OZtZJBFF4Al5XSEJGnqXYq32_F8Vn25Tw_H42uB6qlq42a6O2tdSX_Y1U4B3bFKtk7WLYDhRPwGewLR7AwHP_Jxj_kpQscY68PrN_rdrBy5SgXEnWMPrycm5_O52Gn6fEJ9t48QUy5WmEcHqSyK9MJD4MEBJs8SVeahIgLv2T7MS7ZLpuIy767PbYAOW4JdrmjGuwuQrlZpwRq16bZtkF8smq7GB-8GMyjLTtdeiXgXDamFzG67gdmy75KGFWHqqOlHC8mnaJIqvXSaxBOpY2lAXGBIxmIReKap2C58FvmTYz30yLNGURC5dCR-2LsSFg-dMvT0HbchK--c_ru9MFT14AAXkx8DhOe4Upxf-2wV_fOHNopGyGnQpQqYFQ8qxJeIcY9cp_PRI6y0_KolyFBelx6ma3_kb6wCzHe_XkfN4On2NB6EBAtHpNHIZOhHzwtn5CRaZ6SB_Og1XhGfgE7KfCIRnbSITtpa6ljJ920blRgEUV2UmQn7dhJB-ykwM6AiuykPTsREdlJOY1EowB_k510wM73z8nZ50-Lo2MWNgRhGgJPwUwCrsXoTGgIo_mM10ZoSBlUMi14LYpcCcNVbsvCZDKDqausk5oXUqe2FKYEx_OC7DVtY14SWkBmrnJdiKKegYeyJa8ht7C1FhYymGm9T8bxSVcXvu9L9Xfb7pPDaIwq_mdyy7BXdwI9IA_71-E12dusr8wbiIA36q2j0G9o-rVz |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | ProQuest |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Was+the+Historic+Contribution+of+Spain+to+the+Mexican+Gene+Pool+Partially+Responsible+for+the+Higher+Prevalence+of+Type+2+Diabetes+in+Mexican-Origin+Populations%3F&rft.jtitle=Diabetes+care&rft.au=Lorenzo%2C+Carlos&rft.au=Serrano-Rios%2C+Manel&rft.au=Martinez-Larrad%2C+Maria+T.&rft.au=Gabriel%2C+Rafael&rft.date=2001-12-01&rft.issn=0149-5992&rft.eissn=1935-5548&rft.volume=24&rft.issue=12&rft.spage=2059&rft.epage=2064&rft_id=info:doi/10.2337%2Fdiacare.24.12.2059&rft.externalDBID=n%2Fa&rft.externalDocID=10_2337_diacare_24_12_2059 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon |